The nutritional status of children and adolescents with HIV/AIDS on antiretroviral therapy

Journal of Tropical Pediatrics

Volumn 57, Issue 1, 2011, Pages 65-68

  Souza, Déborah Teixeira ^a   Rondó, Patrícia Helen Carvalho ^a   Reis, Ligia Cardoso ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescents; Anthropometry; Children; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ABDOMINAL OBESITY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAZIL; CHILD; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NUTRITIONAL STATUS; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PREVALENCE; SCAPULA; SCHOOL CHILD; SIDE EFFECT; SKINFOLD THICKNESS; TRICEPS BRACHII MUSCLE; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADOLESCENT; ANTHROPOMETRY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY FAT DISTRIBUTION; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; NUTRITIONAL STATUS; OBESITY; PREVALENCE; SKINFOLD THICKNESS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 79551497707     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq035     Document Type: Article

References (26)

1. UNAIDS. Joint United Nations Programme on HIV/AIDS, World Health Organization. AIDS Epidemic update, 2006.
2. Wachholz NIR, Ferreira J. Adherence to antiretroviral therapy in children: a study of prevalence and associated factors. Cad Saúde Pública 2007;23:S424-34.
3. Galvão J. A política brasileira de distribuição e produção de medicamentos anti-retrovirais: privilégio ou um direito? Cad Saúde Pública 2002;18:213-9.
4. ADA American Dietetic Association. Position of the American Dietetic Association and Dietitians of Canada: nutrition intervention in the care of persons with human immunodeficiency virus infection. J Am Diet Assoc 2004;104:1425-41.
5. Leonard EG, McComsey GA. Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J 2003;22:77-84.
6. Desai N, Mullen P, Mathur M. Lipodystrophy in pediatric HIV. Indian J Pediatr 2008;75:351-4.
7. George JA, Venter WDF, Deventer HEV, et al. A Longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Res Hum Retroviruses 2009;25:771-81.
8. Kruzich LA, Marquis GS, Wilson CM, et al. HIVinfected US youth are at high risk of obesity and poor diet quality: a challenge for improving shortand long-term health outcomes. J Am Diet Assoc 2004;104:1554-60.
9. Frisancho AR. Anthropometric Standards for the Assessment of Growth and Nutritional Status. Ann Arbor: The University of Michigan Press, 1999.
10. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign, Illinois: Human Kinetics Books, 1988.
11. Centers for Disease Control and Prevention and National Center for Health Statistics. CDC Growth Charts: United States, 2000. http://www.cdc.gov/growthcharts/charts.htm (May 2010, date last accessed).
12. World Health Organization. WHO Child Growth Standards. WHO: Switzerland, 2009. http://whglibdoc.who.int/publications/2009/9789241547635_eng.pdf (May 2010, date last accessed).
13. Centers for Disease Control and Prevention. Anthropometric Reference Data for Children and Adults: U.S. Population, 1999-2000. Advance Data [perió dico na internet] 2005.
14. Dzwonek AB, Lawson MS, Cole TJ, et al. Body fat changes and lipodystrophy in HIV-Infected children: impact of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006;43:121-3.
15. Miller TL. Nutrition in paediatric human immunodeficiency virus infection. Proc Nutr Soc 2000;59:155-62.
16. Coutinho JG, Gentil PC, Toral N. Malnutrition and obesity in Brazil: dealing with the problem through a unified nutritional agenda. Cad Saúde Pública 2008;24(Suppl. 2): S332-40.
17. Guillén S, Ramos JT, Resino R, et al. Impact on weight and height with the use of HAART in HIV-Infected children. Pediatr Infect Dis J 2007;26:334-8.
18. Verweel G, Van Rossum AMC, Hartwig NG, et al. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. J Pediatrics 2002;109:E25.
19. Lainka E, Oezbek S, Falck M, et al. Marked dyslipidemia in human immunodeficiency vírus-infected children on protease inhibitor-containing antiretroviral therapy. J Pediatrics 2002;110:E56.
20. Buchacz K, Cervia JS, Lindsey JC, et al. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-1-infected children. J Pediatrics 2001;108:e72.
21. Pollack H, Glasberg H, Lee H, et al. Impaired early growth of infants perinatally infected with human immunodeficiency virus: correlation with viral load. J Pediatrics 1997;130:915-22.
22. Miller TL, Mawn BE, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type-1 infected children. Off J Am Acad Pediatr 2001;107:E77.
23. Torres AMS, Muniz RM, Madero R, et al. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency vírus-infected children. Eur J Pediatr 2005;164:271-6.
24. Alves C, Oliveira AC, Brites C. Lipodystrophic syndrome in children and adolescents infected with human immunodeficiency virus. BJID 2008;12:342-8.
25. Beregszaszi M, Dollfus C, Levine M, et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr 2005;40:161-8.
26. Brambilla P, Bricalli D, Sala N, et al. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 2001;15:2415-22.